국가: 스위스
언어: 독일어
출처: Swissmedic (Swiss Agency for Therapeutic Products)
remdesivirum
Gilead Sciences Switzerland Sàrl
J05A
remdesivirum
Konzentrat zur Herstellung einer Infusionslösung
Lösung: remdesivirum 100 mg, sulfobutylbetadexum natricum 6.36 g, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 20 ml corresp. natrium 417.1 mg.
A
Synthetika
Corona virus disease 2019 (COVID-19)
2020-11-25